|
Market Closed -
Nasdaq
04:00:00 2026-11-18 pm EST
|
5-day change | 1st Jan Change | ||
| 11.25 USD | -0.71% |
|
+10.40% | +82.93% |
| Nov. 13 | ImmuCell Corporation, Q3 2026 Earnings Call, Nov 13, 2026 | |
| Nov. 12 | ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| Market Cap | 103M 93.78M 86.8M 78.27M 147M 9.62B 153M 1.04B 413M 5.19B 386M 378M 16.4B | P/E 2024 |
-19.5x | P/E 2025 | -51.3x |
|---|---|---|---|---|---|
| Enterprise Value | 112M 102M 94.71M 85.41M 161M 10.49B 167M 1.14B 451M 5.67B 421M 412M 17.9B | EV / Sales 2024 |
2.16x | EV / Sales 2025 | 2.35x |
| Free-Float |
67.83% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ICCC | Delayed | |
| ICCC | Real-time | ||
| IUL | Delayed |
Last Transcript: ImmuCell Corporation
| 1 day | -0.71% | ||
| 1 week | +10.40% | ||
| Current month | +9.65% | ||
| 1 month | +4.65% | ||
| 3 months | +15.27% | ||
| 6 months | +13.52% | ||
| Current year | +82.93% |
| 1 week | 10.5 | 11.72 | |
| 1 month | 9.6 | 11.72 | |
| Current year | 5.75 | 12.1 | |
| 1 year | 4.52 | 12.1 | |
| 3 years | 3.34 | 12.1 | |
| 5 years | 3.34 | 12.1 | |
| 10 years | 0 | 13.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 2025-10-31 | |
Timothy Fiori
DFI | Director of Finance/CFO | 47 | 2025-04-06 |
| Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Tomsche
CHM | Chairman | 69 | 2013-11-30 |
Paul Wainman
BRD | Director/Board Member | 61 | 2014-03-30 |
Gloria Basse
BRD | Director/Board Member | 66 | 2020-06-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/15/26 | Free | Chairman | 11,933 | 0.1319% | ||
| 4/15/26 | Free | Director | 17,899 | 0.1979% | ||
| 4/15/26 | Free | Director | 11,933 | 0.1319% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.71% | +10.40% | +146.71% | +136.28% | 103M | ||
| -2.32% | -3.79% | +34.24% | +133.69% | 1,261B | ||
| -2.15% | -2.75% | +36.35% | +82.05% | 671B | ||
| -2.33% | -3.04% | +22.29% | +106.80% | 518B | ||
| -0.69% | +0.40% | +40.46% | +69.78% | 387B | ||
| -3.90% | -6.39% | +42.88% | +35.41% | 353B | ||
| -1.35% | -2.23% | +24.30% | +56.34% | 300B | ||
| -1.13% | -1.80% | +0.59% | +33.00% | 283B | ||
| -3.07% | -5.17% | +29.04% | +67.26% | 248B | ||
| -0.75% | -0.44% | +32.87% | +123.96% | 211B | ||
| Average | -0.97% | +0.85% | +40.97% | +84.46% | 423B | |
| Weighted average by Cap. | -0.77% | -0.55% | +31.08% | +91.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 26.49M 24.14M 22.35M 20.15M 37.97M 2.48B 39.45M 269M 106M 1.34B 99.38M 97.3M 4.22B | 27.64M 25.19M 23.32M 21.03M 39.62M 2.58B 41.16M 281M 111M 1.39B 104M 102M 4.41B |
| Net income | -2.16M -1.97M -1.82M -1.64M -3.09M -202M -3.21M -21.89M -8.66M -109M -8.09M -7.92M -344M | -1.04M -948K -877K -791K -1.49M -97.2M -1.55M -10.56M -4.18M -52.47M -3.9M -3.82M -166M |
| Net Debt | 11.34M 10.34M 9.57M 8.63M 16.25M 1.06B 16.89M 115M 45.56M 572M 42.54M 41.66M 1.81B | 9.39M 8.56M 7.92M 7.14M 13.45M 877M 13.98M 95.3M 37.71M 474M 35.21M 34.48M 1.5B |
Employees
73
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | $11.25 | -0.71% | 10,684 |
| 26-11-17 | $11.33 | -0.79% | 18,535 |
| 26-11-16 | $11.42 | +6.23% | 101,746 |
| 26-11-13 | $10.75 | +5.19% | 40,752 |
| 26-11-12 | $10.22 | +0.29% | 19,304 |
- Stock Market
- Stocks
- ICCC Stock
Select your edition
All financial news and data tailored to specific country editions
















